Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies.
[inclusion body myositis]
The
molecular
basis
of
inflammatory
myopathies
such
as
dermatomyositis
(
DM
)
,
polymyositis
,
and
inclusion
body
myositis
,
which
share
the
characteristics
of
chronic
muscle
inflammation
and
skeletal
muscle
wasting
,
are
poorly
understood
.
As
such
,
effective
targeted
treatments
for
these
diseases
are
lacking
,
resulting
in
critical
unmet
medical
needs
for
these
devastating
diseases
.
The
purpose
of
this
study
was
to
identify
possible
new
targets
for
drug
development
by
exploring
the
mechanism
by
which
inflammation
may
play
a
role
in
the
pathology
of
the
inflammatory
myopathies
.
We
compared
expression
levels
of
inflammatory
cytokines
and
microRNAs
(
miRNAs
)
between
muscle
biopsy
samples
from
patients
with
inflammatory
myopathies
and
those
from
donors
without
myositis
.
In
vitro
human
and
mouse
model
systems
were
then
used
to
characterize
the
role
of
these
cytokines
and
microRNAs
on
myoblast-
to
-myocyte
differentiation
.
We
observed
increased
expression
of
inflammatory
cytokines
,
including
tumor
necrosis
factor
α
(
TNF
α
)
,
interferon-α
(
IFN
α
)
,
IFN
β
,
and
interleukin-
1
β
,
in
different
subtypes
of
inflammatory
myopathies
.
We
observed
decreased
expression
of
microRNA-
1
(
miR-
1
)
,
miR-
133
a
,
and
miR-
133
b
in
all
of
the
inflammatory
myopathy
subtypes
we
evaluated
,
as
well
as
decreased
expression
of
miR-
206
in
DM
;
these
miRNAs
are
essential
for
adult
skeletal
muscle
differentiation
and
maintenance
.
TNF
α
was
significantly
inversely
correlated
with
decreased
myogenic
miRNA
expression
in
the
inflammatory
myopathy
subtypes
.
In
mechanistic
studies
,
TNF
α
inhibited
the
expression
of
myogenic
miRNAs
and
suppressed
the
differentiation
of
C
2
C
12
myoblasts
to
myocytes
/
myotubes
in
an
NF-κB-dependent
manner
.
This
block
in
differentiation
by
TNF
α
was
relieved
by
overexpression
of
miR-
1
,
miR-
206
,
or
miR-
133
a
/
b
.
Taken
together
,
these
results
provide
a
new
mechanistic
link
between
the
action
of
proinflammatory
cytokines
and
the
degenerative
pathology
of
inflammatory
myopathies
,
and
suggest
therapeutic
approaches
for
these
diseases
.
Diseases
Validation
Diseases presenting
"critical unmet medical needs for these devastating diseases"
symptom
inclusion body myositis
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom
